Cancer Research in Nepal

Evidence shows clinically research-oriented hospitals have better patient care outcomes.

Advancing cancer research in Nepal through innovation, collaboration, and patient-centered studies. Explore our research publications and ongoing projects that shape the future of cancer care in Nepal.

Sections

Together, we strive to ensure better patient outcomes, foster community health, and build a brighter future in cancer care.

Overview

The Department of Research and Academics at Kathmandu Cancer Center is committed to advancing cancer care in Nepal through innovative research, educational excellence, and interdisciplinary collaboration. With access to radiation therapy, chemotherapy, immunotherapy, and surgical treatments, our department integrates these advanced modalities with scientific research to improve patient outcomes and pioneer new standards in oncology.

Our mission is to drive innovative research in cancer treatment, diagnostics, prevention, and patient care, deliver comprehensive training for healthcare professionals and students, and contribute significantly to the global understanding and management of cancer. Through rigorous research, hands-on clinical experience, and community-focused initiatives, we aim to elevate oncology practices and cultivate the next generation of cancer care leaders.

Research Team

Key Highlights

  • Academic credentials: PhD from Monash University, PharmD from Kathmandu University, and Bachelor’s in Pharmacy from Purbanchal University.
  • Head of Research and Academics at Kathmandu Cancer Center, focusing on personalized cancer therapies and evidence-based medicine in Nepal.
  • Respected research scientist and senior clinical pharmacist with expertise in clinical pharmacology, oncology, pain management, and pharmacovigilance.
  • Pioneered advancements in cancer pain management, therapeutics, and established a regional pharmacovigilance and drug information center.
  • Visiting faculty in Pharmacology and Toxicology and consultant for Vennue Foundation’s cancer care program in the USA.
  • Recipient of prestigious awards: Young Health Researcher Award (2023) by Nepal Health Research Council and Science and Technology Youth Award (2023-2024) by Nepal Academy of Science and Technology.
  • Published over 90 research articles and 10 book chapters, with over 6,000 citations (H-index: 31, I-10 index: 71).
  • Editorial board member of BMC Health Services Research and PLOS ONE, and reviewer for journals like The Lancet, BMJ Open, and International Journal of Clinical Pharmacy.
  • Research focus on cancer pain management, drug safety, pharmacovigilance, and health outcomes, skilled in systematic reviews and psychometric validation.
  • Passionate mentor, fostering research excellence and clinical expertise through training programs and collaborative research initiatives.

Our Objectives

  1. Innovative Research: We strive to lead high-impact research focused on cancer prevention, innovative treatments, and enhancing patient care to drive advancements in oncology.
  2. Academic Excellence: Our commitment to education involves developing and delivering cutting-edge training programs for healthcare professionals, students, and research scholars, ensuring they are equipped with the latest knowledge in oncology and clinical pharmacology.
  3. Collaboration and Engagement: By fostering interdisciplinary partnerships with national and international institutions, we aim to share knowledge, resources, and research insights to expand the collective understanding and treatment of cancer.
  4. Community and Patient-Centered Initiatives: Through outreach programs, we work to raise community awareness about cancer prevention, early detection, and patient education to support individuals and families affected by cancer.

Key Research Areas

  • Radiation Oncology: Our research in radiation oncology aims to advance cutting-edge techniques such as IMRT, VMAT, and brachytherapy, improving treatment precision, reducing side effects, and optimizing patient outcomes and Quality of Life.
  • Clinical Pharmacology: Our research in clinical pharmacology focuses on tailoring treatment regimens to patients' individual needs, aiming to minimize adverse effects and optimize therapeutic outcomes.
  • Cancer Epidemiology: We investigate cancer risk factors and preventive strategies, with a particular emphasis on public health initiatives designed to reduce cancer incidence locally and globally.
  • Supportive and Palliative Care: We are dedicated to identifying interventions that enhance the quality of life for cancer patients and their families, addressing physical, emotional, and psychological needs, and focusing on patient-reported outcomes (PROs) and quality of life (QoL) assessments to understand patient experiences during treatment better.
  • Nursing Research: Our nursing research is focused on enhancing patient care by developing evidence-based practices that improve the clinical role of nurses in cancer treatment, symptom management, and patient education, with a focus on holistic and supportive care.
  • Public Health Research: We focus on cancer prevention, early detection, and health promotion through public health research, studying interventions that can reduce cancer risks and improve outcomes across populations, particularly in underserved areas.
  • Diagnostics: Our research in diagnostics aims to develop and improve techniques for early cancer detection, focusing on biomarkers, imaging technologies, and screening methods that can lead to earlier and more accurate diagnoses, ultimately enhancing treatment effectiveness.

Ongoing Research at Kathmandu Cancer Center

Investigator ▲▼ Co-Investigator(s) ▲▼ Approved Title ▲▼ NHRC Ref No/IRC ▲▼

Institutional Review Committee

KCC has established a fully operational Institutional Review Committee (IRC) to oversee ethical aspects of human research studies. Our IRC ensures compliance with both national and international clinical research standards.

Key Responsibilities

  • Review research proposals
  • Ensure ethical guideline compliance
  • Researcher training programs
  • Participant safety oversight

Visit IRC Page Download Proposal Form



Research and Academic Collaboration

Kathmandu Cancer Center and Kathmandu University Partner for Cancer Research Collaboration

Kathmandu University (KU) and Kathmandu Cancer Center (KCC) have signed an MoU to collaborate on cancer research and academic exchange. The partnership, established at Nepal Technology Innovation Center in Dhulikhel, aims to advance joint research projects, facilitate academic exchanges, and enhance capacity building in oncology.

Key focus areas include early cancer detection, personalized medicine, and community-based prevention strategies. This collaboration marks a significant step in strengthening cancer research capabilities in Nepal, leveraging KU's academic resources and KCC's clinical expertise.

Collaboration Kathmandu University (KU) and Kathmandu Cancer Center

Kathmandu Cancer Center Joins Forces with Research Institute of Biotechnology and Biosciences

The Research Institute of Biotechnology and Biosciences (RIBB) and Kathmandu Cancer Center (KCC) have signed a MoU to collaborate on cutting-edge cancer research and academic exchange. This partnership aims to initiate joint research projects focusing on advanced diagnostics, early cancer detection, and the development of personalized treatment approaches.

By combining RIBB’s expertise in biotechnology with KCC’s clinical experience, this collaboration is set to enhance cancer research capabilities and improve patient outcomes in Nepal.

Collaboration Research Institute of Biotechnology and Biosciences (RIBB) and Kathmandu Cancer Center

Contact Us

Kathmandu Cancer Center welcomes academic and clinical research collaborations. Join us in advancing oncology research in Nepal and beyond.

For more information about our research initiatives, educational programs, or collaboration opportunities, please contact:

Department of Research and Academics

Get in Touch

Additional Information

  • Comprehensive collaboration proposals are welcome
  • Research internship opportunities are available.


Kathmandu Cancer Centre Research Publications

# Title Authors Journal Year DOI/ Link